← Alle mensen

AW

Andrew Warner

14 publicaties

Publicaties op Oncologisch.com

Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERI...
The Lancet. Oncology · 2026-02
Practical Aspects of Delivering Radiation for Polygemetastaseerd Disease
Int J Radiation Oncology · 9 januari 2026
Dosimetric Uitkomsten for Stereotactic Radiotherapie in Early-Stage Non-Small Cell Longkanker and Interstitial Lung Disease: A Secondary Analyse of the ASPIRE-ILD Trial
Int J Radiation Oncology · 29 september 2025
Dosimetric Uitkomsten of Stereotactic Body Radiotherapie to Ultracentral Lung Tumors: Lessons From the SUNSET Trial
Int J Radiation Oncology · 3 september 2025
Werkzaamheid of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analyse From the International Radiosurgery Oncology Consortium of the Kidney
Int J Radiation Oncology · 2 september 2025
Effects of a high-fiber, high-fruit and high-vegetable, low-fat dietary intervention on the rectal tissue microbiome.
Journal of the National Cancer Institute · 1 juni 2025
Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis o...
European journal of cancer (Oxford, England : 1990) · 2 mei 2025
RT versus TORS bij orofarynxcarcinoom: definitieve resultaten
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024-12
Vijfjaars SABR bij primair niercelcarcinoom: internationale analyse
The Lancet. Oncology · 2022-12
De-escalatie met RT versus TORS bij orofarynxcarcinoom: toxiciteit en overleving
JAMA oncology · 1 juni 2022
Palliatieve RT bij centrale longtumoren met oesofagussparing: PROACTIVE fase II
JAMA oncology · 1 april 2022
RT versus transorale robotchirurgie bij orofarynxcarcinoom: ORATOR2 fase II definitief
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 maart 2022
Radiotherapie versus TORS plus klierdissectie bij orofarynxcarcinoom: ORATOR fase II
The Lancet. Oncology · 2019-10
SABR versus standaard palliatieve RT bij oligometastasen: SABR-COMET fase II
Lancet (London, England) · 18 mei 2019